newsGP - Second SGLT2 inhibitor approved for heart failure - RACGP

Empagliflozin has been added to the PBS for symptomatic heart failure with reduced ejection fraction, regardless of diabetes status.

News Empagliflozin has been added to the PBS for symptomatic heart failure with reduced ejection fraction, regardless of diabetes status. The EMPEROR-Reduced trial found empagliflozin, in addition … [+3433 chars]

full article...